Cáncer Pulmonar de Célula No Pequeñaencontrar mimedicamentoscáncerPostoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trialsMulti-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients with Advanced Non-Small Cell Lung CancerToxicity and Outcome Results of RTOG 93-11: A Phase I-II Dose-Escalation Study Using Three-Dimensional Conformal Radiotherapy in Patients with Inoperable Non-small-cell Lung CarcinomaMolecular Pathological Substaging in 244 Stage I Non-Small Cell Lung Cancer Patients: Clinical ImplicationsRadiosensitization with Carboplatin for Patients with Unresectable Stage III Non-Small-Cell Lung Cancer: A phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology GroupRandomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung CancerA controlled Study of Postoperative Radiotherapy for Patients with Completey Resected Non-Small Cell Lung CarcinomaPhase III Study of Concurrent versus Sequential Thoracic Radiotherapy in Combination with Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non-Small-Cell Lung cancerChemoradiation for Locally Advanced, Unresectable NSCLC-New Standard of Care, Emerging StrategiesProspective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non?Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyRandomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non?Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy RegimensPreoperative Chemotherapy Followed by Concurrent Chemoradiation Therapy Based Hyperfractionated Accelerated Radiotherapy and Definitive Surgery in Locally Advanced Non-Small Cell LungCancer: Mature Results of a Phase II TrialPatterns of Failure after Resection of Non-small-cell lung cancer: Implications for Postoperative Radiation Therapy Volumes
Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
Toxicity and Outcome Results of RTOG 93-11: A Phase I-II Dose-Escalation Study Using Three-Dimensional Conformal Radiotherapy in Patients with Inoperable Non-small-cell Lung Carcinoma
Molecular Pathological Substaging in 244 Stage I Non-Small Cell Lung Cancer Patients: Clinical Implications
Radiosensitization with Carboplatin for Patients with Unresectable Stage III Non-Small-Cell Lung Cancer: A phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
A controlled Study of Postoperative Radiotherapy for Patients with Completey Resected Non-Small Cell Lung Carcinoma
Phase III Study of Concurrent versus Sequential Thoracic Radiotherapy in Combination with Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non-Small-Cell Lung cancer
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non?Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non?Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
Preoperative Chemotherapy Followed by Concurrent Chemoradiation Therapy Based Hyperfractionated Accelerated Radiotherapy and Definitive Surgery in Locally Advanced Non-Small Cell LungCancer: Mature Results of a Phase II Trial
Patterns of Failure after Resection of Non-small-cell lung cancer: Implications for Postoperative Radiation Therapy Volumes